Home | About CDC | Press Room | Funding | A-Z Index | Centers, Institutes & Offices | Training & Employment | Contact Us
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
  Flu Home
  About the Flu
  Arrow Key Facts About Flu
  Arrow Preventing the Flu
  Arrow Flu Activity
  Arrow Q & A
  Arrow Info for Specific Groups
  For Health Professionals
  Arrow Vaccination
  Arrow Clinical Description & Diagnosis
  Arrow Background
  Arrow Training
  Arrow Flu Bulletins
  Arrow Infection Control
  Arrow Antivirals
  Arrow Patient Education
  Arrow References & Resources
  Arrow Surveillance
  See Also…
  Arrow Avian Flu
""    
 What's New | Contact Us
Influenza (Flu) - Protect Yourself and Your Loved Ones
Flu Home > Information for Health Care Professionals > Vaccination >
Comparison of LAIV with Inactivated Influenza Vaccine(See note about the information provided here.)

Both inactivated influenza vaccine and LAIV are available to reduce the risk of influenza infection and illness. However, the vaccines also differ in key ways (Table 3).

Major Similarities

LAIV and inactivated influenza vaccine contain strains of influenza viruses that are antigenically equivalent to the annually recommended strains: one influenza A (H3N2) virus, one A (H1N1) virus, and one B virus. Each year, one or more virus strains might be changed on the basis of global surveillance for influenza viruses and the emergence and spread of new strains. Viruses for both vaccines are grown in eggs. Both vaccines are administered annually to provide optimal protection against influenza infection (Table 3).

Major Differences

Inactivated influenza vaccine contains killed viruses, whereas LAIV contains attenuated viruses still capable of replication. LAIV is administered intranasally by sprayer, whereas inactivated influenza vaccine is administered intramuscularly by injection. LAIV is more expensive than inactivated influenza vaccine. LAIV is approved for use only among healthy persons aged 5–49 years; inactivated influenza vaccine is approved for use among persons aged >6 months, including those who are healthy and those with chronic medical conditions (Table 3).

Table 3

 

*  The text provided here is taken directly from Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (MMWR 28 May 2004;53[RR06]:1-40).

 

    Home   |   Policies and Regulations   |  Disclaimer   |  e-Government   |  FOIA   |   Contact Us  
Safer, Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: 404-639-3311 / Flu Public Inquiries: 800-CDC-INFO • TTY 800-243-7889
Clinician Information Line: 877-554-4625
FirstGovDHHS Department of Health
and Human Services